The analgesic efficacy and safety of nefopam in patient-controlled analgesia after cardiac surgery: A randomized, double-blind, prospective study

Journal of International Medical Research

Volumn 42, Issue 3, 2014, Pages 684-692

  Kim, Kyungmi ^a   Kim, Wook Jong ^a   Choi, Dae Kee ^a   Lee, Yoon Kyung ^b   Choi, In Cheol ^a   Sim, Ji Yeon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

adult cardiac surgery; Nefopam; patient controlled analgesia

Indexed keywords

FENTANYL; NEFOPAM; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HEART SURGERY; HUMAN; INFUSION RATE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PATIENT ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT CONTROLLED ANALGESIC INFUSION PUMP; POSTOPERATIVE ANALGESIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SWEAT GLAND DISEASE; TACHYCARDIA; VISUAL ANALOG SCALE; VOMITING; AGED; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NAUSEA; NEFOPAM; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES;

EID: 84904734395     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060514525351     Document Type: Article

References (28)

1. Beloeil H,Eurin M,Thévenin A, et al.Effective dose of nefopam in 80% of patients (ED80): a study using the continual reassessment method.Br J Clin Pharmacol. 2007;64:686-693.
2. Evans MS,Lysakowski C,Tramèr MR.Nefopam for prevention of postoperative pain: quantitative systematic review.Br J Anaesth. 2008;101:610-617.
3. Bonnet F,Marret E.Influence of anaesthetic and analgesic techniques on outcome after surgery.Br J Anaesth. 2005;95:52-58.
4. Guindon J,Walczak JS,Beaulieu P.Recent advances in the pharmacological management of pain.Drugs. 2007;67:2121-2133.
5. Kehlet H,Dahl JB.The value of "multimodal" or "balanced analgesia" in postoperative pain treatment.Anesth Analg. 1993;77:1048-1056.
6. McLintock TT,Kenny GN,Howie JC, et al.Assessment of the analgesic efficacy of nefopam hydrochloride after upper abdominal surgery: a study using patient controlled analgesia.Br J Surg. 1988;75:779-781.
7. Mimoz O,Incagnoli P,Josse C, et al.Analgesic efficacy and safety of nefopam vs. propacetamol following hepatic resection.Anaesthesia. 2001;56:520-525.
8. Dordoni PL,Della Ventura M,Stefanelli A, et al.Effect of ketorolac, ketoprofen and nefopam on platelet function.Anaesthesia. 1994;49:1046-1049.
9. Gasser JC,Bellville JW.Respiratory effects of nefopam.Clin Pharmacol Ther. 1975;18:175-179.
10. Tirault M,Derrode N,Clevenot D, et al.The effect of nefopam on morphine overconsumption induced by large-dose remifentanil during propofol anesthesia for major abdominal surgery.Anesth Analg. 2006;102:110-117.
11. Daabiss M.American society of Anaesthesiologists physical status classification.Indian J Anaesth. 2011;55:111-115.
12. Minto CF,Schnider TW,Egan TD, et al.Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. model development.Anesthesiology. 1997;86:10-23.
13. Gourlay GK,Kowalski SR,Plummer JL, et al.Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain.Anesth Analg. 1988;67:329-337.
14. Grass JA.Patient-controlled analgesia.Anesth Analg. 2005;101:S44-S61.
15. Ho SC,Royse CF,Royse AG, et al.Persistent pain after cardiac surgery: an audit of high thoracic epidural and primary opioid analgesia therapies.Anesth Analg. 2002;95:820-823.
16. Swarm RA,Karanikolas M,Kalauokalani D.Pain treatment in the perioperative period.Curr Probl Surg. 2001;38:835-920.
17. Watt-Watson J,Stevens B.Managing pain after coronary artery bypass surgery.J Cardiovasc Nurs. 1998;12:39-51.
18. Kruger M,McRae K.Pain management in cardiothoracic practice.Surg Clin North Am. 1999;79:387-400.
19. Reimer-Kent J.From theory to practice: preventing pain after cardiac surgery.Am J Crit Care. 2003;12:136-143.
20. Hunskaar S,Fasmer OB,Broch OJ, et al.Involvement of central serotonergic pathways in nefopam-induced antinociception.Eur J Pharmacol. 1987;138:77-82.
21. Verleye M,André N,Heulard I, et al.Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents.Brain Res. 2004;1013:249-255.
22. Richebé P,Picard W,Rivat C, et al.Effects of nefopam on early postoperative hyperalgesia after cardiac surgery.J Cardiothorac Vasc Anesth. 2013;27:427-435.
23. Esposito E,Romandini S,Merlo-Pich E, et al.Evidence of the involvement of dopamine in the analgesic effect of nefopam.Eur J Pharmacol. 1986;128:157-164.
24. Sunshine A,Laska E.Nefopam and morphine in man.Clin Pharmacol Ther. 1975;18:530-534.
25. Tigerstedt I,Tammisto T,Leander P.Comparison of the analgesic dose-effect relationships of nefopam and oxycodone in postoperative pain.Acta Anaesthesiol Scand. 1979;23:555-560.
26. Urwin SC,Smith HS.Fatal nefopam overdose.Br J Anaesth. 1999;83:501-502.
27. Tracqui A,Berthelon L,Ludes B.Fatal overdosage with nefopam (Acupan).J Anal Toxicol. 2002;26:239-243.
28. Ould-Ahmed M,Drouillard I,El-Kartouti A, et al.Néfopam en perfusion continue et effets indésirables: quelle imputabilité?.Ann Fr Anesth Reanim. 2007;26:74-76.